Europe Multiplex Detection Immunoassay Market Size, Trends & Growth Opportunity, By Assay (Planar Assay and Bead Based Assays), By Application (Disease Testing, Food Contamination Testing, Research & Development and Veterinary Disease Testing), and By Technique (Protein-Based Technique, Biosensor-Based Technique), By End User(Pharmaceutical Companies, Clinical Research Organizations, Food & Beverage Companies, Academic Research Institutes, Diagnostic Centers and Biotechnology Companies), By Region and Forecast Till 2027. 
Europe Multiplex Detection Immunoassay Market 
The Europe Multiplex Detection Immunoassay Market was valued at US$ 0.78 Bn in 2021, estimated to reach US$ 1.35 Bn in 2027 with a CAGR of 9.57% from 2021-2027.
Multiplex detection assays, which concurrently detect and measure many analyses, are a type of immunoassay. By amplifying several targets in a PCR, these assays can collect more data from modest amounts of proteins or other analyses in less time than standard methods (polymerase chain reaction).
Market Drivers
The use of multiplex detection immunoassays as a diagnostic technique for locating several biomarkers linked to various diseases has proven to be successful. The demand for multiplex detection immunoassays is anticipated to rise along with the incidence of infectious and chronic diseases. These tests are now more precise and efficient thanks to developments in multiplex detection immunoassay technology, including as automation and high-throughput screening. New multiplex detection immunoassay platforms have been created as a result of these technological developments, which are more user-friendly and economical.
Market Restraints
Comparing multiplex detection immunoassays to conventional diagnostic techniques might reveal their price. These tests' high price may prevent them from being widely used in some healthcare facilities, especially those with limited resources. The execution of multiplex detection immunoassays can be technically difficult and requires for specific tools and knowledgeable personnel. This may restrict how often these tests are used in healthcare settings, particularly in less developed nations.
Market Segmentation
Europe multiplex detection immunoassay market is segmented into assays, application, technique and end-user. By assays the market is segmented into planner assay and bead based assays. By application the market is segmented into disease testing, food contamination testing, research & development and veterinary disease testing.  By technique the market is segmented into protein-based technique, biosensor-based technique. By end user the market is segmented into pharmaceutical companies, clinical research organizations, food & beverage companies, academic research institutes, diagnostic centers and biotechnology companies.
Country Analysis
The market for multiplex detection immunoassay in Europe is analysed with a focus on several key countries including Germany, the United Kingdom, Italy, France, Sweden, Spain, Turkey, Switzerland, Denmark, Norway, Finland, Iceland, Poland, Luxembourg, the Netherlands, and Belgium.
The primary countries driving growth in the Multiplex Detection Immunoassay market in Europe are Germany, the United Kingdom, France, and Italy. This market is experiencing an uptick in investments from both government entities and private organizations aimed at supporting research and development efforts in small companies focused on improving diagnoses for a variety of chronic and geriatric diseases in the region.
Key Players
Various key players are listed in this report such as Bio-Rad Laboratories Inc., Thermo Fisher Scientific, EMD Millipore (Merck KGaA), Becton, Dickinson and Company, Qiagen N.V., Quansys Biosciences Inc, Luminex Corporation, F. Hoffmann-La Roche Ltd., Danaher Corporation, etc.
Market Taxonomy
By Assay
• Planar Assay 
• Bead Based Assays
By Application
• Disease Testing
• Food Contamination Testing
• Research & Development
• Veterinary Disease Testing
By Technique
• Protein-Based Technique
• Biosensor-Based Technique
By End User
• Pharmaceutical Companies
• Clinical Research Organizations
• Food & Beverage Companies
• Academic Research Institutes
• Diagnostic Centers 
• Biotechnology Companies
By Country
• Germany
• UK
• France
• Turkey
• Switzerland
• Norway
• Sweden
• Spain
• Italy
• Denmark
• Finland
• Iceland
• Poland
• Luxembourg
• Netherlands
• Belgium

Europe Multiplex Detection Immunoassay Market 
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data 
3 Executive Summary
4 Europe Multiplex Detection Immunoassay Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Europe Multiplex Detection Immunoassay Market, By Assay
5.1 Y-o-Y Growth Comparison, By Assay 
5.2 Europe Multiplex Detection Immunoassay Market Share Analysis, By Assay 
5.3 Europe Multiplex Detection Immunoassay Market Size and Forecast, By Assay
5.3.1 Planar assay
5.3.2 Bead based assays
6 Europe Multiplex Detection Immunoassay Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Europe Multiplex Detection Immunoassay Market Share Analysis, By Application
6.3 Europe Multiplex Detection Immunoassay Market Size and Forecast, By Application
6.3.1. Disease Testing
6.3.2 Food Contamination Testing
6.3.3. Research & Development
6.3.4. Veterinary Disease Testing
7 Europe Multiplex Detection Immunoassay Market, By Technique
7.1 Y-o-Y Growth Comparison, By Technique
7.2 Europe Multiplex Detection Immunoassay Market Share Analysis, By Technique
7.3 Europe Multiplex Detection Immunoassay Market Size and Forecast, By Technique
7.3. 1 Protein-Based Technique
7.3.2 Biosensor-Based Technique
8 Europe Multiplex Detection Immunoassay Market, By End User
8.1 Y-o-Y Growth Comparison, By End User
8.2 Europe Multiplex Detection Immunoassay Market Share Analysis, By End User
8.3 Europe Multiplex Detection Immunoassay Market Size and Forecast, By End User 
8.3. 1 Pharmaceutical Companies
8.3.2 Clinical Research Organizations
8.3.3. Food & Beverage Companies
8.3.4. Academic Research Institutes
8.3.5. Diagnostic Centers
8.3.6. Biotechnology Companies
9 Europe Multiplex Detection Immunoassay Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 Europe Multiplex Detection Immunoassay Market Share Analysis, By Assay 
9.3 Europe Multiplex Detection Immunoassay Market Size and Forecast, By Application 
9.4 Europe Multiplex Detection Immunoassay Market Size and Forecast, By Technique
9.5 Europe Multiplex Detection Immunoassay Market Size and Forecast, By End User
9.6 Europe Multiplex Detection Immunoassay Market Size and Forecast, By Country
9.6.1 Germany 
9.6.2 UK
9.6.3 France
9.6.4. Turkey
9.6.5Switerland
9.6.6Norway
9.6.7Sweden
9.6.8Spain
9.6.9Italy
9.6.10Denmark
9.6.11Finland
9.6.12 Iceland
9.6.13Poland
9.6.14 Luxembourg
9.6.15 Netherlands
9.6.17Belguim
10Competitive Analysis
10.1 Competition Dashboard
10.2 Market share Analysis of Top Vendors
10.3 Key Development Strategies
11Company Profiles
11.1 Bio-Rad Laboratories Inc
11.1.1 Overview
11.1.2 Offerings
11.1.3 Key Financials
11.1.4 Business Segment & Geographic Overview
11.1.5 Key Market Developments
11.1.6 Key Strategies
11.2 Thermo Fisher Scientific
11.2.1 Overview
11.2.2 Offerings
11.2.3 Key Financials
11.2.4 Business Segment & Geographic Overview
11.2.5 Key Market Developments
11.2.6 Key Strategies
11.3 EMD Millipore (Merck KGaA)
11.3.1 Overview
11.3.2 Offerings
11.3.3 Key Financials
11.3.4 Business Segment & Geographic Overview
11.3.5 Key Market Developments
11.3.6 Key Strategies
11.4 Becton, Dickinson and Company
11.4.1 Overview
11.4.2 Offerings
11.4.3 Key Financials
11.4.4 Business Segment & Geographic Overview
11.4.5 Key Market Developments
11.4.6 Key Strategies
11.5 Qiagen N.V.
11.5.1 Overview
11.5.2 Offerings
11.5.3 Key Financials
11.5.4 Business Segment & Geographic Overview
11.5.5 Key Market Developments
11.5.6 Key Strategies
11.6 Quansys Biosciences Inc.
11.6.1 Overview
11.6.2 Offerings
11.6.3 Key Financials
11.6.4 Business Segment & Geographic Overview
11.6.5 Key Market Developments
11.6.6 Key Strategies
11.7 Luminex Corporation
11.7.1 Overview
11.7.2 Offerings
11.7.3 Key Financials
11.7.4 Business Segment & Geographic Overview
11.7.5 Key Market Developments
11.7.6 Key Strategies 
11.8 F. Hoffmann-La Roche Ltd
11.8.1 Overview
11.8.2 Offerings
11.8.3 Key Financials
11.8.4 Business Segment & Geographic Overview
11.8.5 Key Market Developments
11.8.6 Key Strategies 
11.9 Danaher Corporation
11.9.1 Overview
11.9.2 Offerings
11.9.3 Key Financials
11.9.4 Business Segment & Geographic Overview
11.9.5 Key Market Developments
11.9.6 Key Strategies